Nathan Tucker, AHA 2019 – Transcriptional Diversity in the Human Heart
Nathan Tucker (Instructor in Medicine, Massachusetts General Hospital and Project Team Lead, Precision Cardiology Laboratory, Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Boston, MA, USA) speaks to us about the topic of his presentation ‘Late-Breaking Basic Science: An Atlas of Transcriptional Diversity in the Human Heart: Analysis of 287,269 Single Cell Transcriptomes From the Four Chambers of the Non-Failing Heart’, presented at the American Heart Association (AHA) Scientific Sessions 2019.
Speaker’s Disclosures: Dr. Tucker has significant research grant from Bayer AG, and from the NHLBI (federal funding).
1. Please tell us about the topic of your presentation? (0:05)
2. What is the next step for this research? (3:09)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Cardiovascular Disease
John Forrest, ACC 2023: Evolut low risk trial, transcatheter versus surgical aortic valve replacement in patients at low surgical risk
The Evolut low risk trial aimed to compare transcatheter versus surgical aortic valve replacement in patients who were at low risk for surgery. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to discuss the eligibility criteria, the key findings and the outlook for […]
John Forrest, ACC 2023: The treatment paradigm for patients with aortic stenosis
The treatment paradigm for aortic stenosis has developed dramatically in the past decade. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to outline and discuss the developments. Dr Forrest presented an abstract entitled ‘Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients […]
Steven Nissen, ACC 2023: Lipid-lowering therapies – current and future options
Many lipid-lowering therapies exist, such as statins to manage and reduce lipid levels. While statins are the most commonly used medication, some patients may need additional interventions to lower their LDL cholesterol levels. In this touchCARDIO interview, we speak with Prof. Steven Nissen (Cleveland Clinic, Cleveland, OH, USA) to explore current and developing novel lipid-lowering […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!